1. Prevalence of diabetes mellitus in Spanish primary care setting and its association with cardiovascular risk factors and cardiovascular diseases. SIMETAP-DM study
- Author
-
Ángela Rodríguez-de-Cossío, Amelia Alcaraz-Bethencourt, Clara Abad-Schilling, Beatriz López-Uriarte, Rosa Ana García-Pliego, Miriam Sánchez-Herráiz, D. Palacios-Martínez, María Rosario Durán-Tejada, Mercedes Rubio-Villar, Antonio Ruiz-García, María Teresa Plata-Barajas, Lidia de-Prado-Prieto, Juan Carlos García-Álvarez, María Rosa García-Redondo, María Carmen Vieira-Pascual, Nuria Escamilla-Guijarro, Juncal Martínez-Irazusta, Rosa Hueso-Quesada, Sonia Redondo-de-Pedro, María Esther Minguela-Puras, Ana María Rey-López, Concepción Zafra-Urango, Mercedes Redondo-Sánchez, Cristina Ciria-de-Pablo, Paula Chao-Escuer, María Prado García-García-Alcañiz, Alejandra Montero-Costa, Mercedes Adrián-Sanz, Ezequiel Arranz-Martínez, José Manuel Blanco-Canseco, Yolanda Hidalgo-Calleja, María Eugenia García-Fernández, Montserrat Rivera-Teijido, Eva Martínez-Cid-de-Rivera, María Luisa Berbil-Bautista, and Teresa Pascual-Val
- Subjects
musculoskeletal diseases ,medicine.medical_specialty ,education.field_of_study ,business.industry ,Medical record ,Population ,General Engineering ,Prevalence ,medicine.disease ,Confidence interval ,Internal medicine ,Diabetes mellitus ,medicine ,Albuminuria ,General Earth and Planetary Sciences ,Observational study ,medicine.symptom ,business ,education ,General Environmental Science ,Kidney disease - Abstract
Introduction The aims of this study were to determine the crude age-and sex-adjusted prevalence rates of diabetes mellitus (DM), type 1 DM (DM1) and type 2 DM (DM2), and to compare the relationship with cardiovascular risk factors, cardiovascular diseases, chronic kidney disease and metabolic diseases among populations with and without DM. Methods SIMETAP-DM is a cross-sectional observational study conducted in a primary care setting, with a random population-based sample of 10,579 adults. Response rate: 66%. The diagnoses of DM, DM1 and DM2 were based on clinical and biochemical criteria and/or the checking of these diagnoses in medical records. The crude and age- and sex-adjusted prevalence rates (standardised with the Spanish population) were calculated. Results The crude prevalence rates of DM1, DM2 and DM were 0.87% (95% confidence interval [95% CI]: 0.67–1.13), 14.7% (95% CI: 13.9–15.6) and 15.6% (95% CI: 14.7–16.5), respectively. The age- and sex-adjusted prevalence rates of DM1, DM2 and DM were 1.0% (1.3% for men and 0.7% for women), 11.5% (13.6% for men and 9.7% for women) and 12.5% (14.9% for men and 10.5% for women), respectively. The prevalence of DM in the population ≥70 years was double (30.3% [95% CI: 28.0–32.7]) that of the population between 40 and 69 years old (15.3% [95% CI: 14.1–16.5%]). Hypertension, peripheral arterial disease, increased weight-to-height ratio, albuminuria, coronary heart disease, atherogenic dyslipidaemia and hypercholesterolaemia were associated with DM. Conclusions In a Spanish primary care setting, the age-adjusted prevalences of DM1, DM2 and DM in the adult population were 1.0, 11.5 and 12.5%, respectively. A third of the population over 70 years old suffered from DM.
- Published
- 2020